When Bell's Palsy Is Cancer: Avoiding Misdiagnosis and Its Implications

Abstract

Background Facial paralysis due to cancer can be misdiagnosed as Bell's palsy. This study aims to clearly identify and quantify diagnostic differentiators and further evaluate the prognostic implications of misdiagnosis.

Methods Adult patients older than 18 years with facial palsy of unknown or cancerous etiology presenting between 2009 and 2023 were reviewed. Patient characteristics, examination findings, and clinical course were compared between facial paralysis patients with cancer misdiagnosed as Bell's palsy (Cancer-Bell's-Palsy group) and patients correctly diagnosed with Bell's palsy (Bell's-Palsy group). Additionally, morbidity and mortality were compared between facial paralysis patients with cancer initially misdiagnosed with Bell's palsy and facial paralysis patients initially correctly diagnosed with cancer (Cancer-Palsy group).

Results Two-hundred and forty-three patients participated including 43 Cancer-Palsy, 18 Cancer-Bell's-Palsy, and 182 Bell's-Palsy patients. Cancer-Bell's-Palsy patients were significantly less likely than Bell's-Palsy patients to develop synkinesis (odds ratio [OR] = 0.0042; 95% confidence interval [CI]: [0.0005–0.0339]; p < 0.0001), significantly more likely to experience gradual onset facial paralysis (OR = 1,004.69; 95% CI: [54.40–18,555.77]; p < 0.0001), and significantly more likely to have additional nonfacial cranial nerve neuropathies (OR = 49.98; 95% CI: [14.61–170.98]; p < 0.0001). Cancer-Bell's-Palsy patients were more likely than Cancer-Palsy patients to have a greater than 6-month period from initial cancer-attributable symptom onset to cancer diagnosis (OR = 47.62; 95% CI: [9.26–250.00]; p < 0.001), stage IV cancer (OR: 12.36; 95% CI: 1.49–102.71; p = 0.006), and decreased duration of life after cancer diagnosis (median [interquartile range], 40.0 [87.0] vs. 12 [56.3] months, respectively; p = 0.025).

Conclusion Facial paralysis related to cancer must be differentiated from Bell's palsy, as misdiagnosis leads to delayed intervention and poorer prognosis. Gradual onset facial palsy, multiple cranial nerve neuropathies, lack of synkinesis, and lack of improvement were nearly definitive differentiators for underlying cancer.

Keywords

facial palsy - cancer - Bell's palsy

^* These authors contributed equally to this manuscript and are the first co-authors.

Publikationsverlauf

Eingereicht: 14. März 2024

Angenommen: 28. August 2024

Accepted Manuscript online:
03. Oktober 2024

Artikel online veröffentlicht:
03. November 2024

• References

• 1 George E, Richie MB, Glastonbury CM. Facial nerve palsy: clinical practice and cognitive errors. Am J Med 2020; 133 (09) 1039-1044
• 2 Alaani A, Hogg R, Saravanappa N, Irving RM. An analysis of diagnostic delay in unilateral facial paralysis. J Laryngol Otol 2005; 119 (03) 184-188
• 3 Bacorn C, Fong NST, Lin LK. Misdiagnosis of Bell's palsy: case series and literature review. Clin Case Rep 2020; 8 (07) 1185-1191
• 4 Boahene DO, Olsen KD, Driscoll C, Lewis JE, McDonald TJ. Facial nerve paralysis secondary to occult malignant neoplasms. Otolaryngol Head Neck Surg 2004; 130 (04) 459-465
• 5 Chung EJ, Matic D, Fung K. et al. Bell's palsy misdiagnosis: characteristics of occult tumors causing facial paralysis. J Otolaryngol Head Neck Surg 2022; 51 (01) 39
• 6 Jackson CG, Glasscock III ME, Hughes G, Sismanis A. Facial paralysis of neoplastic origin: diagnosis and management. Laryngoscope 1980; 90 (10, Pt 1): 1581-1595
• 7 Marzo SJ, Leonetti JP, Petruzzelli G. Facial paralysis caused by malignant skull base neoplasms. Neurosurg Focus 2002; 12 (05) e2
• 8 Quesnel AM, Lindsay RW, Hadlock TA. When the bell tolls on Bell's palsy: finding occult malignancy in acute-onset facial paralysis. Am J Otolaryngol 2010; 31 (05) 339-342
• 9 Nguyen CN, Mallepally N, Tabilona JR, Lu LB. Not so benign Bell's palsy: malignant peripheral nerve sheath tumor of the facial nerve involving the temporal bone. J Gen Intern Med 2021; 36 (04) 1102-1105
• 10 Morris AM, Deeks SL, Hill MD. et al. Annualized incidence and spectrum of illness from an outbreak investigation of Bell's palsy. Neuroepidemiology 2002; 21 (05) 255-261
• 11 Zandian A, Osiro S, Hudson R. et al. The neurologist's dilemma: a comprehensive clinical review of Bell's palsy, with emphasis on current management trends. Med Sci Monit 2014; 20: 83-90
• 12 National Institute on Alcohol Abuse and Alcoholism (NIAAA). Drinking Levels Defined. Bethesda, MD: NIAAA; 2016
• 13 Salles AG, da Costa EF, Ferreira MC, do Nascimento Remigio AF, Moraes LB, Gemperli R. Epidemiologic overview of synkinesis in 353 patients with longstanding facial paralysis under treatment with botulinum toxin for 11 years. Plast Reconstr Surg 2015; 136 (06) 1289-1298
• 14 James JA, Russell WR. Bell's palsy; aetiology, clinical course, and treatment. Lancet 1951; 2 (6682) 519-522
• 15 Crawford KL, Stramiello JA, Orosco RK, Greene JJ. Advances in facial nerve management in the head and neck cancer patient. Curr Opin Otolaryngol Head Neck Surg 2020; 28 (04) 235-240
• 16 Higgins TS, Antonio SA. The role of facial palsy in staging squamous cell carcinoma of the temporal bone and external auditory canal: a comparative survival analysis. Otol Neurotol 2010; 31 (09) 1473-1479
• 17 Jowett N. A general approach to facial palsy. Otolaryngol Clin North Am 2018; 51 (06) 1019-1031
• 18 O TM, Jowett N, Hadlock TA. O TM. Facial palsy: diagnostic and therapeutic management. Otolaryngol Clin North Am 2018; 51 (06) xvii-xviii
• 19 Chow LQM. Head and neck cancer. N Engl J Med 2020; 382 (01) 60-72
• 20 Goy J, Hall SF, Feldman-Stewart D, Groome PA. Diagnostic delay and disease stage in head and neck cancer: a systematic review. Laryngoscope 2009; 119 (05) 889-898